Alkermes Announces Third Annual Competitive Grants Programs To Support Those Affected By Mental Health & Addiction Disorders

Biopharmaceutical company Alkermes plc (Alkermes) recently announced it is accepting applications for its 3rd annual Alkermes Inspiration Grants program. The program awards upwards to $1 million to organizations for the implementation of innovative, high-impact, and replicable programs that positively impact people with mental health and addiction disorders.

According to Alkermes leadership, the program—which is accepting applications through October 2—highlights both the innovation that exists in the industry, as well as the lack of resources available for those with mental health needs. Specifically, the award grants from the program will seek to address two areas: the improvement of . . .